Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study.
Haematologica
; 92(8): 1083-90, 2007 Aug.
Article
em En
| MEDLINE
| ID: mdl-17640853
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Purging da Medula Óssea
/
Transplante de Células-Tronco de Sangue Periférico
/
Mieloma Múltiplo
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article